Although preclinical studies link GLP-1 signaling to brown adipose tissue (BAT) activation and adipose tissue browning, human data indicate that BAT mass and thermogenic capacity in adulthoodparticularly in obesityare limited, constraining the contribution of energy expenditure to sustained weight loss
Semaglutide, a type of GLP-1R agonists with 94% sequence homology to GLP-1 and with an extended half-life of approximately 1 week, has been clinically approved to treat T2DM and is available in subcutaneous and oral dosage form (136, 137)
Patients enrolled in the Transition Anywhere virtual program have access to prescription weight loss medications, including GLP-1 injections, as part of their medically supervised plan
Pharmaceutical companies then launch education programs for healthcare professionals and patient onboarding initiatives to ensure proper prescription and adherence
Consumption of cruciferous vegetables rich in GLs/ITCs modulates the gut microbiota composition affecting the hosts health